Table 3.
Enrichment Results of KEGG Metabolic Pathways of the 2 Modules.
| Module | ID | Description | P value | Count |
|---|---|---|---|---|
| Black | hsa04720 | Long-term potentiation | 8.11E-06 | 6 |
| hsa04724 | Glutamatergic synapse | 1.68E-05 | 7 | |
| hsa04072 | Phospholipase D signaling pathway | 6.34E-04 | 6 | |
| Lightcyan | hsa04080 | Neuroactive ligand-receptor interaction | 3.47E-10 | 28 |
| hsa04724 | Glutamatergic synapse | 4.77E-10 | 18 | |
| hsa04020 | Calcium signaling pathway | 1.04E-09 | 22 | |
| hsa04727 | GABAergic synapse | 4.01E-08 | 14 | |
| hsa05033 | Nicotine addiction | 4.22E-08 | 10 | |
| hsa05031 | Amphetamine addiction | 1.01E-06 | 11 | |
| hsa05032 | Morphine addiction | 3.07E-06 | 12 | |
| hsa05030 | Cocaine addiction | 3.36E-06 | 9 | |
| hsa04721 | Synaptic vesicle cycle | 3.81E-06 | 10 | |
| hsa04728 | Dopaminergic synapse | 5.31E-06 | 14 | |
| hsa04713 | Circadian entrainment | 5.43E-06 | 12 | |
| hsa04024 | cAMP signaling pathway | 1.15E-05 | 17 | |
| hsa04725 | Cholinergic synapse | 2.68E-05 | 12 | |
| hsa04921 | Oxytocin signaling pathway | 3.47E-05 | 14 | |
| hsa04360 | Axon guidance | 3.92E-05 | 15 | |
| hsa04911 | Insulin secretion | 5.72E-05 | 10 | |
| hsa04014 | Ras signaling pathway | 2.24E-04 | 16 | |
| hsa04742 | Taste transduction | 2.54E-04 | 9 | |
| hsa04720 | Long-term potentiation | 2.89E-04 | 8 | |
| hsa04723 | Retrograde endocannabinoid signaling | 3.97E-04 | 12 | |
| hsa00220 | Arginine biosynthesis | 1.78E-03 | 4 | |
| hsa04726 | Serotonergic synapse | 2.39E-03 | 9 | |
| hsa04964 | Proximal tubule bicarbonate reclamation | 2.54E-03 | 4 | |
| hsa04971 | Gastric acid secretion | 2.98E-03 | 7 | |
| hsa04925 | Aldosterone synthesis and secretion | 4.91E-03 | 7 | |
| hsa04010 | MAPK signaling pathway | 5.79E-03 | 14 | |
| hsa04924 | Renin secretion | 6.20E-03 | 6 | |
| hsa05034 | Alcoholism | 6.46E-03 | 11 | |
| hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 6.75E-03 | 5 |